-
Posted by
Two Blokes Jul 2 -
Filed in
Stock
-
8 views
PRINCETON, N.J. , July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions in the intensive care unit and cardiac surgery, today provided a regulatory update on its marketing applications for DrugSorb\u2122-ATR with the U.S. Food and Drug Administration (FDA) and Health Canada.